Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,898 | -17,927 | -101,695 | -78,847 | -56,703 |
| Depreciation Amortization | -170 | 19 | -256 | -293 | -299 |
| Accounts payable and accrued liabilities | -1,975 | -1,210 | 421 | 2,090 | 409 |
| Other Working Capital | -3,124 | -3,637 | 336 | -403 | -2,527 |
| Other Operating Activity | 6,462 | 4,107 | 17,052 | 12,291 | 11,051 |
| Operating Cash Flow | $-34,705 | $-18,648 | $-84,142 | $-65,162 | $-48,069 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -50 | -212 | -163 | -107 |
| Purchase Of Investment | -130,240 | -124,486 | -51,593 | -45,619 | -41,177 |
| Sale Of Investment | 31,750 | 19,500 | 134,391 | 117,135 | 91,245 |
| Investing Cash Flow | $-98,513 | $-105,036 | $82,586 | $71,353 | $49,961 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | -1,305 | -435 | N/A | N/A |
| Debt Repayment | -3,152 | -307 | -929 | -704 | -544 |
| Common Stock Issued | 150,780 | 150,670 | 38 | 16 | 15 |
| Other Financing Activity | -17,896 | -9,463 | 1,688 | 372 | 372 |
| Financing Cash Flow | $139,732 | $139,595 | $362 | $-316 | $-157 |
| Beginning Cash Position | 16,439 | 16,439 | 17,633 | 17,633 | 17,633 |
| End Cash Position | 22,953 | 32,350 | 16,439 | 23,508 | 19,368 |
| Net Cash Flow | $6,514 | $15,911 | $-1,194 | $5,875 | $1,735 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,705 | -18,648 | -84,142 | -65,162 | -48,069 |
| Capital Expenditure | -67 | -50 | -212 | -163 | -107 |
| Free Cash Flow | -34,772 | -18,698 | -84,354 | -65,325 | -48,176 |